Kazia Therapeutics-Spon ADRKZIA
13F holders, Q3 2025 (September 30)11holders +1
3new positions
2sold out
$7.21avg. 13F price*
At the end of Q3 2025, 11 institutions reported holding Kazia Therapeutics-Spon ADR (KZIA) in their 13F filings, up 1 from Q2 2025. 3 opened new positions and 2 sold out. The largest holders were Dauntless Investment Group, LLC ($852K), Barclays PLC ($173K) and Rockefeller Capital Management L.P. ($77K).
- Company
- Kazia Therapeutics-Spon ADR
- CUSIP
- 48669G303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $83K |
| Exits | 2 | $2K |
All 13F filers, Q2 2025 → Q3 2025: 14,423 shares bought and 365 shares sold, net +14,058 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Dauntless Investment Group, LLC | 2.23% | Add +2.0% | 118,139 | $852K |
| Barclays PLC | 0.00% | No change | 24,000 | $173K |
| Rockefeller Capital Management L.P. | 0.00% | New | 10,700 | $77K |
| UBS Group AG | 0.00% | Add +17.0% | 3,543 | $26K |
| Citigroup Inc. | 0.00% | New | 639 | $5K |
| Rhumbline Advisers | 0.00% | No change | 591 | $4K |
| Morgan Stanley | 0.00% | New | 200 | $1K |
| Arax Advisory Partners | 0.00% | No change | 200 | $1K |
| MAI Capital Management | 0.00% | No change | 52 | $375 |
| Osaic Holdings, Inc. | 0.00% | No change | 10 | $74 |
| Allworth Financial LP | 0.00% | No change | 1 | $8 |
"% of holder's portfolio" is KZIA's weight in each manager's 13F, not the share of Kazia Therapeutics-Spon ADR the manager owns.